|
|
See Category: Diseases of the nervous system
ICD-10 (CM) Code and Descriptor
|
G50.9 |
Disorder of trigeminal nerve, unspecified
|
G509 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 40.95%
|
21.26%
|
11.73%
|
8.09%
|
4.66%
|
3.40%
|
3.09%
|
2.02%
|
0.96%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G50.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
414
|
417
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
162
|
163
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
133
|
134
|
|
97110
|
THERAPEUTIC EXERCISES |
112
|
197
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
105
|
105
|
|
80053
|
COMPREHEN METABOLIC PANEL |
84
|
84
|
|
97530
|
THERAPEUTIC ACTIVITIES |
82
|
142
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
81
|
81
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
61
|
61
|
|
J0585
|
INJECTION,ONABOTULINUMTOXINA |
58
|
5,500
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
51
|
51
|
|
G1004
|
CDSM NDSC |
48
|
51
|
|
82565
|
ASSAY OF CREATININE |
45
|
45
|
|
64612
|
DESTROY NERVE FACE MUSCLE |
43
|
43
|
|
A9585
|
GADOBUTROL INJECTION |
42
|
3,415
|
|
A9577
|
INJ MULTIHANCE |
40
|
503
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
40
|
57
|
|
G0467
|
FQHC VISIT, ESTAB PT |
34
|
34
|
|
80048
|
METABOLIC PANEL TOTAL CA |
33
|
33
|
|
86235
|
NUCLEAR ANTIGEN ANTIBODY |
32
|
70
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G50.9 related to the following DRG Codes:
073-074
|
